-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FgBLdRznDo34aONwAzujKdXTkizmNc9DUEAGHIvs5kiLfaRSlVRQtyVHSyKn21bT gO06TrDv6jM5TIcbXmo8jw== 0001072613-07-002608.txt : 20071107 0001072613-07-002608.hdr.sgml : 20071107 20071107112424 ACCESSION NUMBER: 0001072613-07-002608 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071107 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: POWER MEDICAL INTERVENTIONS INC CENTRAL INDEX KEY: 0001098274 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83327 FILM NUMBER: 071220179 BUSINESS ADDRESS: STREET 1: 110 UNION SQUARE DR CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 267-775-8100 MAIL ADDRESS: STREET 1: 110 UNION SQUARE DR CITY: NEW HOPE STATE: PA ZIP: 18938 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 SC 13G 1 power-medical_15531a.txt BOSTON SCIENTIFIC CORPORATION SCHEDULE 13G ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )(1) POWER MEDICAL INTERVENTIONS, INC. ------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value per share ------------------------------------------------------- (Title or Class of Securities) 739299105 ------------------------------------------------------- (CUSIP Number) October 31, 2007 ------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) - ------------------ (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ =================== =========== CUSIP NO. 739299105 13G PAGE 2 OF 5 =================== =========== ================================================================================ 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Boston Scientific Corporation 04-2695240 - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [_] (B) [_] - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------- ------------------------------------------------------------------------ 5 SOLE VOTING POWER 2,205,417 NUMBER OF ------- ----------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH ------- ----------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 2,205,417 ------- ----------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - ------- ------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,205,417 - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 13.3% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON* CO ================================================================================ *SEE INSTRUCTIONS BEFORE FILLING OUT! =================== =========== CUSIP NO. 739299105 13G PAGE 3 OF 5 =================== =========== ITEM 1(A). NAME OF ISSUER: Power Medical Interventions, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 2021 Cabot Boulevard Langhorne, PA 19047 ITEM 2(A). NAME OF PERSON FILING: Boston Scientific Corporation ITEM 2(B). ADDRESS OF PRINICIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: One Boston Scientific Place Natick, MA 01760 ITEM 2(C). CITIZENSHIP: Delaware Corporation ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock, $0.001 par value per share ITEM 2(E). CUSIP NUMBER: 739299105 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with ss. 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). =================== =========== CUSIP NO. 739299105 13G PAGE 4 OF 5 =================== =========== ITEM 4. OWNERSHIP: (a) Amount beneficially owned: 2,205,417 (b) Percent of class: 13.3% (c) Number of shares as to which such person has: (i) Sole Power to vote or to direct the vote: 2,205,417 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,205,417 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: [ ] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Inapplicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Inapplicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Inapplicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Inapplicable. ITEM 10. CERTIFICATIONS: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. - ------------------------------- =================== =========== CUSIP NO. 739299105 13G PAGE 5 OF 5 =================== =========== SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 7, 2007 - -------------------------- (Date) BOSTON SCIENTIFIC CORPORATION /s/ Lawrence J. Knopf --------------------------------------- Name: Lawrence J. Knopf Senior Vice President and Deputy General Counsel -----END PRIVACY-ENHANCED MESSAGE-----